Wolverine Trading’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.11M | Sell |
25,100
-3,600
| -13% | -$439K | ﹤0.01% | 1784 |
|
|
2025
Q2 | $3.44M | Sell |
28,700
-10,600
| -27% | -$1.19M | ﹤0.01% | 1308 |
|
|
2025
Q1 | $4.42M | Buy |
39,300
+24,600
| +167% | +$2.62M | 0.01% | 1056 |
|
|
2024
Q4 | $1.43M | Sell |
14,700
-500
| -3% | -$53.3K | ﹤0.01% | 2299 |
|
|
2024
Q3 | $1.76M | Buy |
+15,200
| New | +$1.72M | ﹤0.01% | 1809 |
|
|
2024
Q2 | – | Sell |
-18,300
| Closed | -$1.77M | – | 5006 |
|
|
2024
Q1 | $1.77M | Buy |
18,300
+12,400
| +210% | +$1.27M | ﹤0.01% | 1699 |
|
|
2023
Q4 | $596K | Sell |
5,900
-24,500
| -81% | -$2.36M | ﹤0.01% | 2770 |
|
|
2023
Q3 | $3.1M | Buy |
30,400
+12,100
| +66% | +$1.23M | ﹤0.01% | 1296 |
|
|
2023
Q2 | $1.82M | Buy |
18,300
+2,000
| +12% | +$200K | ﹤0.01% | 1534 |
|
|
2023
Q1 | $1.49M | Buy |
+16,300
| New | +$1.42M | ﹤0.01% | 1583 |
|
|
2022
Q3 | – | Sell |
-12,700
| Closed | -$1.08M | – | 5103 |
|
|
2022
Q2 | $1.08M | Sell |
12,700
-800
| -6% | -$70.2K | ﹤0.01% | 1853 |
|
|
2022
Q1 | $1.19M | Sell |
13,500
-34,200
| -72% | -$2.96M | ﹤0.01% | 2274 |
|
|
2021
Q4 | $4.17M | Buy |
47,700
+15,200
| +47% | +$1.26M | ﹤0.01% | 1269 |
|
|
2021
Q3 | $2.69M | Buy |
+32,500
| New | +$2.92M | ﹤0.01% | 1829 |
|
|
2021
Q2 | – | Sell |
-43,400
| Closed | -$3.78M | – | 6486 |
|
|
2021
Q1 | $3.78M | Buy |
+43,400
| New | +$3.89M | 0.01% | 1351 |
|
|
2020
Q3 | – | Sell |
-49,400
| Closed | -$4.31M | – | 4953 |
|
|
2020
Q2 | $4.31M | Sell |
49,400
-8,600
| -15% | -$742K | 0.01% | 893 |
|
|
2020
Q1 | $4.75M | Sell |
58,000
-8,400
| -13% | -$749K | 0.01% | 794 |
|
|
2019
Q4 | $6.28M | Buy |
66,400
+26,800
| +68% | +$2.4M | 0.02% | 937 |
|
|
2019
Q3 | $3.46M | Sell |
39,600
-14,000
| -26% | -$1.26M | 0.01% | 1077 |
|
|
2019
Q2 | $4.89M | Sell |
53,600
-18,270
| -25% | -$1.55M | 0.01% | 892 |
|
|
2019
Q1 | $6.19M | Buy |
71,870
+5,580
| +8% | +$448K | 0.02% | 755 |
|
|
2018
Q4 | $5.06M | Buy |
66,290
+23,770
| +56% | +$1.85M | 0.01% | 803 |
|
|
2018
Q3 | $3.28M | Buy |
+42,520
| New | +$3.14M | 0.01% | 1258 |
|
|
2018
Q1 | – | Sell |
-47,988
| Closed | -$3.61M | – | 5614 |
|
|
2017
Q4 | $3.61M | Buy |
+47,988
| New | +$3.62M | 0.01% | 1078 |
|
|
2017
Q1 | – | Sell |
-47,318
| Closed | -$3.09M | – | 4772 |
|
|
2016
Q4 | $3.09M | Buy |
47,318
+12,945
| +38% | +$840K | 0.02% | 1048 |
|
|
2016
Q3 | $2.44M | Buy |
34,373
+20,200
| +143% | +$1.47M | 0.01% | 1194 |
|
|
2016
Q2 | $1.03M | Buy |
+14,173
| New | +$979K | 0.01% | 1569 |
|
Other funds holding NVS
Wolverine Trading's NVS Position: Q3 2025 in Review
Wolverine Trading reduced its Novartis (NVS) stake by 53% in Q3 2025, selling an estimated $618K and leaving 4,415 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #3607.
Wolverine Trading first reported a position in NVS in Q2 2016 and has held it in 21 quarters since. The position peaked at $5M in Q2 2019. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.
- Wolverine Trading held 4,415 shares of Novartis worth $548K as of Q3 2025.
- Wolverine Trading sold 5,061 Novartis shares in Q3 2025, an estimated $618K.
- Novartis made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3607 holding.
- Wolverine Trading first reported a position in Novartis in Q2 2016 and has held it in 21 quarters since.
- Wolverine Trading's Novartis position peaked at $5M in Q2 2019.
- 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.